Urinary transforming growth factor-β₁, collagen IV and the effect of insulin in children at diagnosis of diabetes mellitus

References

• Lehmann R, Schleicher E. Molecular mechanism of diabetic nephropathy. Clin Chim Acta 2000; 297: 135–44
   PubMed Web of Science ®Google Scholar
• Drummond K, Mauer SM. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002; 51: 1580–7
   PubMed Web of Science ®Google Scholar
• Sato H, Iwano M, Akai Y. Increased excretion of urinary transforming growth factor beta1 in patients with diabetic nephropathy. Am J Nephrol 1998; 18: 490–4
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN. Renal tubular basement membrane and collagen type IV in diabetes mellitus. Kidney Int 1993; 43: 114–20
   PubMed Web of Science ®Google Scholar
• Nicholas SB. Advances in pathogenetic mechanisms of diabetic nephropathy. Cell Mol Biol 2003; 49: 1319–25
   PubMed Web of Science ®Google Scholar
• Shankland SJ, Scholeya JW. Expression of transforming growth factor β1 during diabetic renal hypertrophy. Kidney Int 1994; 46: 430–42
   PubMed Web of Science ®Google Scholar
• Hoffman BB, Sharma K, Ziyadeh FN. Potential role of TGF-β in diabetic nephropathy. Miner Electrolyte Metab 1998; 24: 190–6
   PubMedGoogle Scholar
• Fagerudd J, Groop P-H, Honkanen E, Teppo A-M, Grönhagen-Riska C. Urinary excretion of TGF-β1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney Int 1997; 52(Suppl 63)195–7
   PubMedGoogle Scholar
• Ziyadeh FN. Mediators of diabetic renal disease: the case for TGF-β as the major mediator. J Am Soc Nephrol 2004; 15: 55–7
   PubMed Web of Science ®Google Scholar
• Chen S, Jim B, Ziyadeh FN. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 2003; 23: 532–43
   PubMed Web of Science ®Google Scholar
• Border WA, Noble NA. Evidence that TGF-β should be a therapeutic target in diabetic nephropathy. Kidney Int 1998; 54: 1390–1
   PubMed Web of Science ®Google Scholar
• de Dios ST, Frontanilla KV, Nigro J, Ballinger ML, Ivey ME, Cawson EA, et al. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents. J Diabetes Complications 2007; 21: 108–17
   PubMed Web of Science ®Google Scholar
• Torffvit O, Agardh C-D, Cederholm B, Wieslander J. A new enzyme linked immunosorbent assay for urine and serum concentrations of the carboxyterminal domain (NC1) of collagen IV. Application in type 1 (insulin-dependent) diabetes. Scand J Clin Lab Invest 1989; 49: 431–9
   PubMed Web of Science ®Google Scholar
• Ellis D, Forrest KY, Erbey J, Orchard TJ. Urinary measurement of transforming growth factor-β and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Clin Chem 1998; 44: 950–6
   PubMed Web of Science ®Google Scholar
• Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Nephrol 2006; 17: 1703–9
   PubMed Web of Science ®Google Scholar
• Flores L, Naf S, Hernaez R, Conget I, Gomis R, Esmatjes E. Transforming growth factor beta at clinical onset of type 1 diabetes mellitus. A pilot study. Diabet Med 2004; 21: 818–22
   PubMed Web of Science ®Google Scholar
• De Muro P, Faedda R, Fresu P, Masala A, Cigni A, Concas G, et al. Urinary transforming growth factor-β1 in various types of nephropathy. Pharmacol Res 2004; 49: 293–8
   PubMed Web of Science ®Google Scholar
• Korpinen E, Teppo AM, Hukkanen L, Åkerblom HK, Grönhagen-Riska C, Vaarala O. Urinary transforming growth factor-β and α1-microglobulin in children and adolescents with type 1 diabetes. Diabetes Care 2000; 23: 664–8
   PubMed Web of Science ®Google Scholar
• Cummings EA, Cameron FJ, Sochett EB. Urinary TGF-β is associated with kidney size but not albumin excretion rate in children and adolescents with type 1 diabetes. Diabetes 1999; 48(Suppl 1)140
   Google Scholar
• Gilbert RE. Expression of transforming growth factor-β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes. Diabetes 1998; 47: 414–22
   PubMed Web of Science ®Google Scholar
• Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M. Long-term prevention of renal insufficiency, excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 2000;97:8015–20.
   PubMed Web of Science ®Google Scholar
• Benigni A, Zoja C, Corna D, Zatelli C, Conti S, Campana M, et al. Add-on anti-TGF-β antibody to ACE inhibitor arrests progressive diabetic nephropathy in the rat. J Am Soc Nephrol 2003; 14: 1816–24
   PubMed Web of Science ®Google Scholar
• Torffvit O, Wieslander J. A simplified enzyme-linked immunosorbent assay for urinary albumin. Scand J Clin Lab Invest 1986; 46: 545–8
   PubMed Web of Science ®Google Scholar
• Torffvit O, Agardh C-D, Kjellsson B, Wieslander J. Tubular secretion of Tamm-Horsfall protein in type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. Clin Chim Acta 1992; 205: 31–41
   PubMed Web of Science ®Google Scholar
• Tencer J, Torffvit O, Thysell H, Grubb A, Rippe B. Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis. Nephrol Dial Transpl 1997; 12: 1161–6
   PubMed Web of Science ®Google Scholar
• Frutos TB. Normal Anatomy and Variants. In: Carty H, Brunelle F, Stringer DA, Kan SCS. Imaging children. 2nd ed. New York: Elsevier Churchill Livingstone; 2005. p 567–71.
   Google Scholar
• Krutzen E, Bäck SE, Nilsson-Ehle P. Plasma clearance of a new contrast agent, iohexol: a method for the assessment of glomerular filtration rate. J Lab Clin Med 1984; 104: 955–61
   PubMed Web of Science ®Google Scholar
• Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CDA, EURODIAB Prospective Complication Study Group. Circulating and urinary transforming growth factor β1, amadori albumin, and complications of type 1 diabetes. Diabetes Care 2002;25:2320–7.
   PubMed Web of Science ®Google Scholar
• Drummond K. Young kidneys respond differently than adult kidneys to insulin dependent diabetes mellitus. Diabetic Nephropathy Study Group. J Am Soc Nephrol 1990; 1: 307
   Google Scholar
• Feldt-Rasmussen B, Hegedus L, Mathiesen ER, Deckert T. Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control. Scand J Clin Lab Invest 1991; 51: 31–6
   PubMed Web of Science ®Google Scholar
• Baumgartl H-J, Sigl G, Banholzer P, Haslbeck M, Standl E. On the prognosis of IDDM patients with large kidneys. Nephrol Dial Transplant 1998; 13: 630–4
   PubMed Web of Science ®Google Scholar
• Torffvit O, Wieslander J, Forsberg L, Hederström E, Agardh CD. Urinary excretion of the carboxy terminal domain of type IV collagen is associated with kidney size and function in IDDM. J Diabetes Complications 1990; 4: 166–9
   Google Scholar
• Rasch R, Torffvit O, Bachmann S, Jensen PK, Jacobsen NO. Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabetologia 1995; 38: 525–35
   PubMed Web of Science ®Google Scholar
• Cohen MP, Lautenslager GT, Shearman CW. Increased collagen IV excretion in diabetes. A marker of compromised filtration function. Diabetes Care 2001; 24: 914–8
   PubMed Web of Science ®Google Scholar
• Watanabe H, Sanada H, Shigetomi S, Katoh T, Watanabe T. Urinary excretion of type IV collagen as a specific indicator of the progression of diabetic nephropathy. Nephron 2000; 86: 27–35
   PubMed Web of Science ®Google Scholar
• Chiarelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing albuminuria in diabetic children. Pediatr Nephrol 1995; 9: 154–8
   PubMed Web of Science ®Google Scholar
• Levy-Marchal C, Laborde K, Kindermans C, Dechaux M, Czernichow P. Persisting glomerular hyperfiltration in short-term diabetic children without microalbuminuria. Acta Paediatr Scand 1989; 78: 712–6
   PubMed Web of Science ®Google Scholar
• Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration as a predictor of diabetic nephrology, an 8 year prospective study. Kidney Int 1992; 41: 822–8
   PubMed Web of Science ®Google Scholar
• Mogensen CE, Christensen CK, Pedersen MM, Alberti KGMM, Boye N, Christensen T, et al. Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. J Diabetes Complications 1990; 4: 159–65
   Google Scholar